Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?

Eur J Neurol. 2007 Aug;14(8):e21-2. doi: 10.1111/j.1468-1331.2007.01873.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Autoantibodies / analysis
  • Autoantibodies / blood*
  • Brain / immunology*
  • Brain / physiopathology*
  • Cholinesterase Inhibitors / therapeutic use
  • Electroencephalography
  • Epilepsy / immunology*
  • Epilepsy / physiopathology
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Memory Disorders / immunology
  • Memory Disorders / physiopathology
  • Muscle Weakness / complications*
  • Muscle Weakness / immunology
  • Muscle Weakness / physiopathology
  • Muscle, Skeletal / immunology
  • Muscle, Skeletal / innervation
  • Muscle, Skeletal / physiopathology
  • Myasthenia Gravis / complications*
  • Myasthenia Gravis / immunology
  • Myasthenia Gravis / physiopathology
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Prednisone / therapeutic use
  • Pyridostigmine Bromide / therapeutic use
  • Receptor Protein-Tyrosine Kinases / immunology*
  • Receptors, Cholinergic / immunology*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Autoantibodies
  • Cholinesterase Inhibitors
  • Immunoglobulins, Intravenous
  • Receptors, Cholinergic
  • MUSK protein, human
  • Receptor Protein-Tyrosine Kinases
  • Mycophenolic Acid
  • Pyridostigmine Bromide
  • Prednisone